● Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Condition: Metastatic Clear Cell Renal Cell Carcinoma · Advanced Clear Cell Renal Cell Carcinoma · Sponsor: Arcus Biosciences, Inc.

PhasePhase 3

Planned participants720

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of the study is to evaluate the progression-free survival (PFS) of casdatifan versus placebo when each is given in combination with cabozantinib in adult patients with confirmed advanced or metastatic clear cell Renal Cell Carcinoma who have experienced progression on or after prior anti-PD-1 or anti-PD-L1 immunotherapy.

This description comes directly from the study's public registry record.

Talk to the study team

Medical Director · +1-510-462-3330 · clinicaltrials@arcusbio.com

Always discuss trial participation with your own doctor first.

Locations (134)

Research Site	Gilbert, Arizona, United States	Recruiting
Research Site	Goodyear, Arizona, United States	Recruiting
Research Site	Phoenix, Arizona, United States	Recruiting
Research Site	Duarte, California, United States	Recruiting
Research Site	La Jolla, California, United States	Recruiting
Research Site	Los Angeles, California, United States	Recruiting
Research Site	Sacramento, California, United States	Recruiting
Research Site	San Diego, California, United States	Recruiting
Research Site	New Haven, Connecticut, United States	Recruiting
Research Site	Washington D.C., District of Columbia, United States	Recruiting
Research Site	Jacksonville, Florida, United States	Recruiting
Research Site	Miami, Florida, United States	Recruiting

+ 122 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07011719